Document is current
Any future updates will be listed below
-
Authors
Jameson, T. S. O.
Caldow, M. K.
Stephens, F.
Denehy, L.
Lynch, G. S.
Koopman, R.
Krajcova, A.
Urban, T.
Berney, S.
Duska, F.
Puthucheary, Z.
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council of Australia (App1079460, App1079460, App1079460)
Agentura pro zdravotnicky vyzkum of the Czech Ministry of Health (16-28663A and NU21J-06-00078, 16-28663A and NU21J-06-00078, 16-28663A and NU21J-06-00078)
- License Information
-
More Information
Article History
Received: 29 August 2023
Accepted: 26 September 2023
First Online: 6 November 2023
Declarations
:
: Applicable for both human and/or animal studies. Ethical committees, Internal Review Boards and guidelines followed must be named. When applicable, additional headings with statements on consent to participate and consent to publish are also required.
: Z. A. P. reports personal fees from Faraday Pharmaceuticals, Lyric Pharmaceuticals, Bioage Fresenius Kabi, Nestlé, Orion and GlaxoSmithKline, outside the submitted work.
